Reshma Rangwala - Net Worth and Insider Trading
Reshma Rangwala Net Worth
The estimated net worth of Reshma Rangwala is at least $298,350 dollars as of 2024-11-13. Reshma Rangwala is the EVP & Chief Medical Officer of Karyopharm Therapeutics Inc and owns about 342,931 shares of Karyopharm Therapeutics Inc (KPTI) stock worth over $298,350. Details can be seen in Reshma Rangwala's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Reshma Rangwala has not made any transactions after 2024-04-22 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Reshma Rangwala
Reshma Rangwala Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Reshma Rangwala owns 2 companies in total, including Aravive Inc (ARAV) , and Karyopharm Therapeutics Inc (KPTI) .
Click here to see the complete history of Reshma Rangwala’s form 4 insider trades.
Insider Ownership Summary of Reshma Rangwala
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ARAV | Aravive Inc | 2020-09-28 | Chief Medical Officer |
| KPTI | Karyopharm Therapeutics Inc | 2024-04-22 | EVP & Chief Medical Officer |
Reshma Rangwala Latest Holdings Summary
Reshma Rangwala currently owns a total of 1 stock. Reshma Rangwala owns 342,931 shares of Karyopharm Therapeutics Inc (KPTI) as of April 22, 2024, with a value of $298,350.
Latest Holdings of Reshma Rangwala
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| KPTI | Karyopharm Therapeutics Inc | 2024-04-22 | 342,931 | 0.87 | 298,350 |
Holding Weightings of Reshma Rangwala
Reshma Rangwala Form 4 Trading Tracker
According to the SEC Form 4 filings, Reshma Rangwala has made a total of 3 transactions in Karyopharm Therapeutics Inc (KPTI) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in Karyopharm Therapeutics Inc is the sale of 6,789 shares on April 22, 2024, which brought Reshma Rangwala around $7,943.
Insider Trading History of Reshma Rangwala
- 1
Reshma Rangwala Trading Performance
Reshma Rangwala Ownership Network
Ownership Network List of Reshma Rangwala
Ownership Network Relation of Reshma Rangwala
Reshma Rangwala Owned Company Details
What does Aravive Inc do?
Who are the key executives at Aravive Inc?
Reshma Rangwala is the Chief Medical Officer of Aravive Inc. Other key executives at Aravive Inc include Chief Commercial Officer Maria Carolina Petrini , Chief Medical Officer Robert B. Geller , and Chief Financial Officer Rudy Howard .
Aravive Inc (ARAV) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Aravive Inc (ARAV) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Aravive Inc (ARAV) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Aravive Inc (ARAV)'s detailed insider trading history can be found in Insider Trading Tracker table.
Aravive Inc Insider Transactions
Reshma Rangwala Mailing Address
Above is the net worth, insider trading, and ownership report for Reshma Rangwala. You might contact Reshma Rangwala via mailing address: River Oaks Tower, 3730 Kirby Drive, Suite 1200, Houston Tx 77098.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
